N/A N=48

Cohort Isolation and Cross-infection in Bronchiolitis

Bronchiolitis

Bottom Line

View on ClinicalTrials.gov: NCT01441466 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jul 2015

Primary outcome: Primary: Duration of Hospital Stay — 3.9; 2.1 days

Study Design & Population

Study type: Observational
Phase: N/A
Interventions: Isolation (Other)
Age: Pediatric
Sex: All
Sponsor: Princess Amalia Children's Clinic
Primary completion: Mar 2012

Outcome Measures

Outcome	Result	p-value
PRIMARY Duration of Hospital Stay	3.9; 2.1	—
SECONDARY Number of Days With Tube Feeding	2.2; 0.7	—
SECONDARY Supplemental Oxygen Needed	2.1; 1.1	—
SECONDARY Highest Dyspnoea Score	3.4; 2.9	—
SECONDARY Mechanical Ventilation	2; 1	—
SECONDARY Cross-infection	0; 2	—

Summary

The purpose of this study is to investigate the effect of cohort isolation of RS(respiratory syncytial virus)-positive bronchiolitis versus RS-negative bronchiolitis on prevention of co-infection and clinical disease severity. Furthermore the investigators want to elucidate general epidemiological data on bronchiolitis concerning viral causes and the associated clinical severity. The investigators want to conduct a prospective cohort study, comparing incidence of co-infection and clinical severity, in two cohort: one with isolation of RS positive bronchiolitis as a separate cohort within bronchiolitis and one without isolation (all children with RS-negative bronchiolitis are nursed together independent of viral agent)

Eligibility Criteria

Inclusion Criteria

patients under 2 years of age
hospitalized for bronchiolitis

Exclusion Criteria

bronchopulmonary disease
congenital heart defect,
congenital pulmonary disease,
Down's syndrome

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01441466). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.